The new policy, quietly announced in March in a Technical Bulletin from the National Library of Medicine, comes 13 months after the nonprofit Center for Science in the Public Interest and six other organizations, 62 scientists and physicians, and five United States Senators asked the NLM and the National Institutes of Health to publish the disclosures.
POTENTIAL PROBLEM: Big Pharma is still heavily involved (see image & link below)
POTENTIAL PROBLEM: Big Pharma is still heavily involved (see image & link below)
RSS Feed